Last update 21 Nov 2024

G-207

Overview

Basic Info

Drug Type
Oncolytic virus
Synonyms
Mechanism
RNR inhibitors(Ribonucleotide reductase inhibitors)
Inactive Indication
Originator Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
-G-207-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Primitive Neuroectodermal TumorsPhase 1
US
01 May 2016
Supratentorial NeoplasmsPhase 1
US
01 May 2016
GliomaPhase 1
US
01 May 2005
GliomaPhase 1
US
01 May 2005
GlioblastomaPhase 1-01 Dec 2001
Recurrent Malignant GliomaPhase 1-01 Dec 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
12
(nqwtudirru) = No serious adverse events were attributed to G207 by the investigators mskdsnpcds (vhiaxnjrsc )
Positive
29 Apr 2021
Phase 1
9
(bthiywwmha) = 20 serious adverse events occurred in this study, only 3 were possible/probable related to G207/irradiation wbxlackzry (cwmxkfanre )
Positive
20 May 2009
(Irradiation)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free